

Everything you need to know about Rectiv (nitroglycerin 0.4% ointment) — what it treats, how to use it, dosage instructions, cost, and availability in 2026.
Rectiv is the brand name for nitroglycerin 0.4% rectal ointment, the only FDA-approved topical medication specifically designed to treat moderate-to-severe pain associated with chronic anal fissures. It was approved by the FDA in 2011 and is manufactured by Allergan (now part of AbbVie).
If you've been dealing with the sharp, burning pain of an anal fissure that hasn't healed with basic home treatments, Rectiv may be the next step your doctor recommends. This guide covers everything patients need to know about Rectiv in 2026 — from how it works to how much it costs.
Rectiv is indicated for one specific condition: moderate-to-severe pain caused by chronic anal fissures.
An anal fissure is a small tear or cut in the lining of the anus. These tears are surprisingly common and can cause intense, sharp pain during and after bowel movements, along with bright red bleeding. Common causes include:
Most anal fissures are acute — they heal on their own within 4-6 weeks with conservative measures like increased fiber intake, stool softeners, warm sitz baths, and topical pain relievers. When a fissure doesn't heal within 6-8 weeks, it's considered chronic. Chronic fissures often develop a cycle where the internal anal sphincter spasms, reducing blood flow to the area and preventing healing.
This is exactly where Rectiv comes in. By relaxing the internal anal sphincter, it breaks this cycle and promotes healing. For a deeper look at the science, see our guide on how Rectiv works.
Rectiv's active ingredient is nitroglycerin — the same compound used in heart medications, but in a much lower concentration and applied locally. When applied to the anal canal, nitroglycerin is converted to nitric oxide (NO), which:
Think of it like this: the fissure can't heal because the muscle around it keeps squeezing tight. Rectiv tells that muscle to relax, giving the fissure the breathing room it needs to close up.
The standard Rectiv dosage is:
Like all medications, Rectiv can cause side effects. The most common include:
Most side effects are temporary and improve within the first week of treatment. For a complete guide on managing side effects and knowing when to seek help, read our detailed article on Rectiv side effects.
Rectiv is not safe for everyone. You should not use Rectiv if you:
Be sure to tell your doctor about all medications you take. For more details, see our guide on Rectiv drug interactions.
Rectiv is not a cheap medication. Here's what to expect in 2026:
Don't let sticker shock stop you from getting treatment. There are several ways to reduce the cost:
For a complete breakdown of savings strategies, read our guide on how to save money on Rectiv.
One of the biggest challenges patients face is simply finding Rectiv in stock. As a single-source brand medication for a niche condition, supply has been inconsistent. If you're struggling to locate Rectiv, use MedFinder to check pharmacy availability in real time.
Rectiv is one of several treatment options for chronic anal fissures:
| Treatment | Type | How It Works |
|---|---|---|
| Rectiv (nitroglycerin 0.4%) | Topical ointment | Relaxes anal sphincter via nitric oxide |
| Diltiazem cream | Compounded topical | Calcium channel blocker that relaxes sphincter |
| Botox injection | In-office procedure | Paralyzes sphincter muscle temporarily |
| Lateral internal sphincterotomy | Surgery | Permanently cuts part of the sphincter muscle |
Rectiv is typically tried before more invasive options. If Rectiv is unavailable or not working, your doctor can discuss alternatives.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.